Physical Medicine & Rehabilitation Doctors in Tempe, AZ Accepting Medicare

8 Physical Medicine & Rehabilitation doctors found. Showing 1 - 8

Victoria Valenzuela, Physical Medicine & Rehabilitation - Neuromuscular Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 W Elliot Rd Ste 109, Tempe, AZ 85284 Phone: 480-374-4341

Ms. Alex Kellett, P.T.A. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1400 E Southern Ave, Ste 310, Tempe, AZ 85282 Phone: 480-721-0758    Fax: 602-438-0350

Rebecca Glubb, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1400 E Southern Ave, Tempe, AZ 85282 Phone: 520-485-7801

Dr. Paul Singh Sraow, M.D. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 E Southern Ave, Ste I-1, Tempe, AZ 85282 Phone: 480-420-3600

Ryan Eugene Denny, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2525 S Rural Rd Ste 5s, Tempe, AZ 85282 Phone: 480-921-9000    Fax: 480-718-8160

Joseph E Logar Iii, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 950 W Southern Ave, Tempe, AZ 85282 Phone: 615-778-4066

Dalton Derthick, PT, DPT, CSCS Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4703 S Lakeshore Dr Ste 2, Tempe, AZ 85282 Phone: 480-718-9493

Carly Rose Guzman, OTR/L Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1972 E Baseline Rd Ste 103, Tempe, AZ 85283 Phone: 480-730-0501

News Archive

Cancer drug Gleevec may hold promise against scleroderma: Study

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.

Kanazawa University researchers describe genetic typing of Pseudomonas putida

Pseudomonas putida is a bacterium occuring in soil, aquatic environments and plants. Although the virulence of Pseudomonas p. - the ability of the bacterium to infect its host and inflict a disease - is considered to be low, infection in severely ill patients can be lethal. P. putida strains (also called isolates) have been found in hospitals, e.g. in urine, blood or wound discharge from patients, and such clinical isolates have been found to display resistance to drugs.

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

​The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood.

Father's cocaine use may make sons less sensitive to drug and more likely to resist addictive behaviors

A father's cocaine use may make his sons less sensitive to the drug and thereby more likely to resist addictive behaviors, suggests new findings from an animal study presented by Penn Medicine researchers at Neuroscience 2013, the annual meeting of the Society for Neuroscience.

Clinicians override most electronic medication safety alerts

Computer-based systems that allow clinicians to prescribe drugs electronically are designed to automatically warn of potential medication errors, but a new study reveals clinicians often override the alerts and rely instead on their own judgment.

Read more Medical News

› Verified 3 days ago